Related Experiment Video
Updated: Oct 24, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Case Report of Midazolam Withdrawal-Induced Catatonia in a 9-Year-Old Patient
Cassandra R Duncan-Azadi1, Peter N Johnson, Andrew Gormley
1From the Departments of *Anesthesiology; †Pharmacy: Clinical and Administrative Sciences; and ‡Pediatrics, Critical Care, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Abstract:
Benzodiazepine withdrawal-induced catatonia is a rare phenomenon in the adult population and has never been reported in a pediatric patient. We present a 9-year-old boy who exhibited catatonia symptoms following discontinuation of a midazolam infusion in the pediatric intensive care unit. The pediatric anesthesia acute pain team was consulted. When the patient's altered mental status could not otherwise be explained, benzodiazepine withdrawal-induced catatonia was considered. A dose of 2 mg intravenous lorazepam was given and the patient's symptoms dramatically improved within 5 minutes of administration. The patient was successfully treated with an oral diazepam taper.
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Toxidromes: Clinical Features
REM Sleep Behavior Disorder
RBD is significantly associated with...
Narcolepsy

